Assignee
PROXIMAGEN LTD
GB·15 granted patents·20 pending applications·72 citations·filing 2003–2017
Top patents by PatentIndex Score
35 records- 0191US9951068B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2017·Granted Apr 24, 2018·8 cites·21 claims
- 0291US9676769B2Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitorsPROXIMAGEN LTD·Filed 2014·Granted Jun 13, 2017·11 cites·9 claims
- 0391US9428498B2Substituted imidazo[4,5-c]pyridine compounds and compositions thereofPROXIMAGEN LTD·Filed 2014·Granted Aug 30, 2016·11 cites·16 claims
- 0484US8377986B2Amino acid derivativesPROXIMAGEN LTD·Filed 2008·Granted Feb 19, 2013·5 cites·4 claims
- 0583US10065954B2Substituted imidazo[4,5-c]pyridines as SSAO inhibitorsPROXIMAGEN LTD·Filed 2015·Granted Sep 4, 2018·5 cites·17 claims
- 0681US9580415B2CompoundsPROXIMAGEN LTD·Filed 2014·Granted Feb 28, 2017·9 cites·20 claims
- 0780US9493457B24,5,6,7-tetrahyroimidazo[4,5-c]pyridine compoundsPROXIMAGEN LTD·Filed 2015·Granted Nov 15, 2016·2 cites·8 claims
- 0876US9890160B2Compounds IPROXIMAGEN LTD·Filed 2016·Granted Feb 13, 2018·1 cites·16 claims
- 0973US9035066B2Method of using 4,5,6,7-tetrahydroimidazo[4,5-C]pyridine compoundsPROXIMAGEN LTD·Filed 2013·Granted May 19, 2015·1 cites·20 claims
- 1073US8377941B2Indoles as modulators of nicotinic acetylcholine receptor subtype alpha-7PROXIMAGEN LTD·Filed 2009·Granted Feb 19, 2013·2 cites·4 claims
- 1171US9499510B2Pro-drug compoundsPROXIMAGEN LTD·Filed 2013·Granted Nov 22, 2016·3 cites·16 claims
- 1270US8835439B2Pharmaceutical composition containing (2R)-methyl-1-3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinylpiperazine L-malate for treatment of serotonin-related diseasesPROXIMAGEN LTD·Filed 2013·Granted Sep 16, 2014·1 cites·10 claims
- 1369US7943639B2CompoundsPROXIMAGEN LTD·Filed 2003·Granted May 17, 2011·9 cites·41 claims
- 1469US7790687B2Treatment for neurodegenerationPROXIMAGEN LTD·Filed 2006·Granted Sep 7, 2010·2 cites·5 claims
- 1567US7960374B2Tricyclic compounds, compositions, and methods useful in the treatment or prophylaxis of 5-HT6 receptor-related disordersPROXIMAGEN LTD·Filed 2007·Granted Jun 14, 2011·2 cites·14 claims
- 1659US2014329826A1(2r)-1-(3-chloro-2-pyrazinyl)-2-methylpiperazine and salts thereofPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 1756US2016016929A1Pro-drug compoundsPROXIMAGEN LTD·Filed 2013·Application pending·0 cites
- 1856US2014275068A1Pro-drug compoundsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 1954US2016113893A1New therapeutic uses of enzyme inhibitorsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 2053US2016046606A1CXCR4 Receptor AntagonistsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 2153US2014206662A1Imidazopyridine CompoundsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 2252US2015038517A1Indole Derivative Modulators of the alpha 7 nAChRPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 2352US2014107150A1New Compounds IIPROXIMAGEN LTD·Filed 2013·Application pending·0 cites
- 2450US2015005321A1Indole and azaindole modulators of the alpha 7 nAChRPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 2549US2016115147A1Pro-drug compoundsPROXIMAGEN LTD·Filed 2016·Application pending·0 cites
- 2648US2016318891A1Tonabersat prodrugsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 2746US2016318892A1Prodrug compoundsPROXIMAGEN LTD·Filed 2014·Application pending·0 cites
- 2845US2009239941A1Amino acid derivativesPROXIMAGEN LTD·Filed 2007·Application pending·0 cites
- 2945US2009170937A1Amino Acid DerivativesPROXIMAGEN LTD·Filed 2007·Application pending·0 cites
- 3043US2018104223A1Treatment of painPROXIMAGEN LTD·Filed 2016·Application pending·0 cites
- 3143US2015239905A1Imidazopyridine compoundsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 3242US2016101072A1Therapeutic uses of enzyme inhibitorsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 3340US2015258101A1New compoundsPROXIMAGEN LTD·Filed 2015·Application pending·0 cites
- 3438US2006264371A1TreatmentPROXIMAGEN LTD·Filed 2006·Application pending·0 cites
- 3532US2008070952A1Inhibition or Treatment of DyskinesiaPROXIMAGEN LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PROXIMAGEN LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →